163 related articles for article (PubMed ID: 35634444)
1. Comprehensive Analysis of DNA Methylation and Transcriptome to Identify PD-1-Negative Prognostic Methylated Signature in Endometrial Carcinoma.
Cao L; Ma X; Rong P; Zhang J; Yang M; Wang W
Dis Markers; 2022; 2022():3085289. PubMed ID: 35634444
[TBL] [Abstract][Full Text] [Related]
2. Identification of methylation-driven genes prognosis signature and immune microenvironment in uterus corpus endometrial cancer.
Liu J; Ji C; Wang Y; Zhang C; Zhu H
Cancer Cell Int; 2021 Jul; 21(1):365. PubMed ID: 34246261
[TBL] [Abstract][Full Text] [Related]
3. Significance of a PTEN Mutational Status-Associated Gene Signature in the Progression and Prognosis of Endometrial Carcinoma.
Wu Y; Wang J; Ge L; Hu Q
Oxid Med Cell Longev; 2022; 2022():5130648. PubMed ID: 35251475
[TBL] [Abstract][Full Text] [Related]
4. Establishment and validation of a prognostic nomogram based on a novel five-DNA methylation signature for survival in endometrial cancer patients.
Li X; Yin F; Fan Y; Cheng Y; Dong Y; Zhou J; Wang Z; Li X; Wang J
Cancer Med; 2021 Jan; 10(2):693-708. PubMed ID: 33350104
[TBL] [Abstract][Full Text] [Related]
5. Identification of DNA methylation associated gene signatures in endometrial cancer via integrated analysis of DNA methylation and gene expression systematically.
Men C; Chai H; Song X; Li Y; Du H; Ren Q
J Gynecol Oncol; 2017 Nov; 28(6):e83. PubMed ID: 29027401
[TBL] [Abstract][Full Text] [Related]
6. A gene signature driven by abnormally methylated DEGs was developed for TP53 wild-type ovarian cancer samples by integrative omics analysis of DNA methylation and gene expression data.
Zhou Z; Jin H; Xu J
Ann Transl Med; 2023 Jan; 11(1):20. PubMed ID: 36760264
[TBL] [Abstract][Full Text] [Related]
7. A 14-Methylation-Driven Differentially Expressed RNA as a Signature for Overall Survival Prediction in Patients with Uterine Corpus Endometrial Carcinoma.
Zeng Z; Cheng J; Ye Q; Zhang Y; Shen X; Cai J; Li M
DNA Cell Biol; 2020 Jun; 39(6):975-991. PubMed ID: 32397815
[TBL] [Abstract][Full Text] [Related]
8. Identification of aberrantly methylated differentially expressed genes and associated pathways in endometrial cancer using integrated bioinformatic analysis.
Liu J; Wan Y; Li S; Qiu H; Jiang Y; Ma X; Zhou S; Cheng W
Cancer Med; 2020 May; 9(10):3522-3536. PubMed ID: 32170852
[TBL] [Abstract][Full Text] [Related]
9. Establishment of a nine-gene prognostic model for predicting overall survival of patients with endometrial carcinoma.
Ying J; Wang Q; Xu T; Lyu J
Cancer Med; 2018 Jun; 7(6):2601-2611. PubMed ID: 29665298
[TBL] [Abstract][Full Text] [Related]
10. An immune-related pseudogene signature to improve prognosis prediction of endometrial carcinoma patients.
Tang S; Zhuge Y
Biomed Eng Online; 2021 Jun; 20(1):64. PubMed ID: 34193185
[TBL] [Abstract][Full Text] [Related]
11. A ten-gene methylation signature as a novel biomarker for improving prediction of prognosis and indicating gene targets in endometrial cancer.
Li X; Yang X; Fan Y; Cheng Y; Dong Y; Zhou J; Wang Z; Li X; Wang J
Genomics; 2021 Jul; 113(4):2032-2044. PubMed ID: 33915245
[TBL] [Abstract][Full Text] [Related]
12. Protein-based prognostic signature for predicting the survival and immunotherapeutic efficiency of endometrial carcinoma.
Lai J; Xu T; Yang H
BMC Cancer; 2022 Mar; 22(1):325. PubMed ID: 35337291
[TBL] [Abstract][Full Text] [Related]
13. Establishing a Prognostic Signature Based on Epithelial-Mesenchymal Transition-Related Genes for Endometrial Cancer Patients.
Liu J; Cui G; Shen S; Gao F; Zhu H; Xu Y
Front Immunol; 2021; 12():805883. PubMed ID: 35095892
[TBL] [Abstract][Full Text] [Related]
14. Construction of a novel mRNA-signature prediction model for prognosis of bladder cancer based on a statistical analysis.
Li J; Cao J; Li P; Yao Z; Deng R; Ying L; Tian J
BMC Cancer; 2021 Jul; 21(1):858. PubMed ID: 34315402
[TBL] [Abstract][Full Text] [Related]
15. Identification of a metabolism-related gene expression prognostic model in endometrial carcinoma patients.
Jiang P; Sun W; Shen N; Huang X; Fu S
BMC Cancer; 2020 Sep; 20(1):864. PubMed ID: 32894095
[TBL] [Abstract][Full Text] [Related]
16. Prognostic evaluation of the novel blueprint of DNA methylation sites by integrating bulk RNA-sequencing and methylation modification data in endometrial cancer.
Zhou H; Zhang Y; Jin J; Shen K; Yang Y; Lao P
J Gene Med; 2024 Jan; 26(1):e3638. PubMed ID: 38011892
[TBL] [Abstract][Full Text] [Related]
17. A robust twelve-gene signature for prognosis prediction of hepatocellular carcinoma.
Ouyang G; Yi B; Pan G; Chen X
Cancer Cell Int; 2020; 20():207. PubMed ID: 32514252
[TBL] [Abstract][Full Text] [Related]
18. Establishment of prognostic risk model and drug sensitivity based on prognostic related genes of esophageal cancer.
Dai J; Reyimu A; Sun A; Duoji Z; Zhou W; Liang S; Hu S; Dai W; Xu X
Sci Rep; 2022 May; 12(1):8008. PubMed ID: 35568702
[TBL] [Abstract][Full Text] [Related]
19. Integrative Analysis of DNA Methylation and Gene Expression Identify a Three-Gene Signature for Predicting Prognosis in Lower-Grade Gliomas.
Zeng WJ; Yang YL; Liu ZZ; Wen ZP; Chen YH; Hu XL; Cheng Q; Xiao J; Zhao J; Chen XP
Cell Physiol Biochem; 2018; 47(1):428-439. PubMed ID: 29794476
[TBL] [Abstract][Full Text] [Related]
20. Development and Validation of a 5-Gene Autophagy-Based Prognostic Index in Endometrial Carcinoma.
Chen X; Zhang W; Zhu H; Lin F
Med Sci Monit; 2021 Feb; 27():e928949. PubMed ID: 33577492
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
